pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
bleximenib besylate
Refractory Acute Myeloid Leukemia
$JNJ
JOHNSON & JOHNSON
0
catalysts
Phase 2
bocunebart
bocunebart [INN]
Migraine
H. Lundbeck AS
0
catalysts
Phase 2
bosakitug
bosakitug [INN]
Atopic Dermatitis (Atopic Eczema)
$ACRS
Aclaris Therapeutics, Inc.
0
catalysts
Phase 2
← prev
page 33 of 50
next →
131
Pain
89
Neurology
1
botensilimab
Metastatic Colorectal Cancer
$AGEN
AGENUS INC
0
catalysts
Phase 2
botulinum vaccine [serogroups A, A1, B and B1]
Botulism
U.S. Army Medical Research Institute of Infectious Diseases
0
catalysts
Phase 2
brexucabtagene autoleucel
Tecartus (brexucabtagene autoleucel)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
B-lymphocyte antigen CD19
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 2
brilacidin
Chemotherapy Induced Oral Mucositis
Innovation Pharmaceuticals Inc
0
catalysts
Phase 2
briquilimab
Chronic Urticaria
Mast/stem cell growth factor receptor Kit
$JSPR
Jasper Therapeutics, Inc.
0
catalysts
Phase 2
brogidirsen
Duchenne Muscular Dystrophy
Nippon Shinyaku Co Ltd
0
catalysts
Phase 2
budoprutug
budoprutug [INN]
Membranous Glomerulonephritis
$CLYM
Climb Bio, Inc.
0
catalysts
Phase 2
buloxibutid sodium
Idiopathic Pulmonary Fibrosis
Vicore Pharma AB
0
catalysts
Phase 2
bulumtatug fuvedotin
bulumtatug fuvedotin [INN]
Esophageal Squamous Cell Carcinoma (ESCC)
Mabwell Shanghai Bioscience Co Ltd
0
catalysts
Phase 2
bupropion
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
Sodium-dependent dopamine transporter
Sodium-dependent noradrenaline transporter
Bioron Pharma
0
catalysts
Phase 2
cabiralizumab
cabiralizumab [INN]
Pigmented Villonodular Synovitis
Bristol-Myers Squibb Co
0
catalysts
Phase 2
cafelkibart
cafelkibart [INN]
Solid Tumor
LaNova Medicines Ltd
0
catalysts
Phase 2
caffeine
Respiratory Depression (Hypoventilation)
Adenosine receptor
OYE Therapeutics Inc
0
catalysts
Phase 2
calpurbatug
calpurbatug [INN]
Prosthetic Joint infections
Trellis Bioscience Inc
0
catalysts
Phase 2
camonsertib
Solid Tumor
XenoTherapeutics Inc
0
catalysts
Phase 2
camupepimut
Colorectal Cancer
$ELTX
Elicio Therapeutics, Inc.
0
catalysts
Phase 2
canerpaturev
Metastatic Melanoma
Takara Bio Inc
0
catalysts
Phase 2
cannabidivarin
Autism Spectrum Disorder (ASD)
$JAZZ
Jazz Pharmaceuticals plc
0
catalysts
Phase 2
canvuparatide hydrochloride
Hypoparathyroidism
$MBX
MBX Biosciences, Inc.
0
catalysts
Phase 2
carbon monoxide
Sickle Cell Disease
Hillhurst Biopharmaceuticals Inc
0
catalysts
Phase 2
carotuximab
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endoglin
$KAPA
Kairos Pharma, LTD.
0
catalysts
Phase 2
casdozokitug
Hepatocellular Carcinoma
$CHRS
Coherus Oncology, Inc.
0
catalysts
Phase 2
cemacabtagene ansegedleucel
Primary Mediastinal B-Cell Lymphoma
$ALLO
Allogene Therapeutics, Inc.
0
catalysts
Phase 2
cemsidomide
Anaplastic Large Cell Lymphoma (ALCL)
$CCCC
C4 Therapeutics, Inc.
0
catalysts
Phase 2
cenegermin
Oxervate (cenegermin-bkbj)
Non-Arteritic Anterior Ischemic Optic Neuropathy
Neurotrophic tyrosine kinase receptor
Dompe Farmaceutici SpA
0
catalysts
Phase 2
censavudine
Amyotrophic Lateral Sclerosis
Human immunodeficiency virus type 1 reverse transcriptase
Reverse transcriptase
Transposon Therapeutics Inc
0
catalysts
Phase 2
cerebrolysin
Unspecified Neurologic Disorders
EVER Neuro Pharma GmbH
0
catalysts
